Groups compared | GG + GA versus AA | GG versus AG + AA | G allele versus A allele | ||||||
---|---|---|---|---|---|---|---|---|---|
OR | 95 % CI | P-value | OR | 95 % CI | P-value | OR | 95 % CI | P-value | |
All patients (n = 587) versus all controls (n = 628) | 1.58 | 1.09—2.30 | 0.016 | 1.20 | 0.95—1.50 | 0.12 | 1.21 | 1.03—1.44 | 0.024 |
Gender groups | Â | Â | Â | Â | Â | Â | Â | Â | Â |
 Male (124 patients vs. 143controls) | 0.82 | 0.52—1.28 | 0.33 | 1.13 | 0.44—2.56 | 0.71 | 0.90 | 0.55—1.36 | 0.46 |
 Female (453 patients vs. 485 controls) | 1.89 | 1.25—2.87 | 0.008 | 1.28 | 0.85—1.75 | 0.53 | 1.56 | 1.08—2.49 | 0.012 |
Age groups | Â | Â | Â | Â | Â | Â | Â | Â | Â |
 ≤65 years (285 patients vs. 278 controls) | 1.48 | 1.18—2.36 | 0.028 | 0.95 | 0.68—1.32 | 0.65 | 1.26 | 1.04—1.58 | 0.045 |
 >65 years (302 patients vs. 350 controls) | 1.72 | 1.13—2.53 | 0.020 | 1.13 | 0.84—1.56 | 0.18 | 1.38 | 1.13—1.57 | 0.037 |
K/L grading groups | Â | Â | Â | Â | Â | Â | Â | Â | Â |
 Mild OA (292 patients vs. 628 controls) | 1.53 | 1.05—2.47 | 0.022 | 1.08 | 0.86—1.29 | 0.31 | 1.30 | 1.05—1.62 | 0.013 |
 Severe OA (295 patients vs. 628 controls) | 1.05 | 0.67—1.64 | 0.84 | 0.95 | 0.70—1.30 | 0.73 | 0.98 | 0.78—1.25 | 0.91 |